Walleye Capital LLC Bluebird Bio, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $102,024 - $247,650	-3,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $399,160 - $524,195	-8,500 Reduced 68.55%	3,900 $342,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $356,820 - $558,600	6,000 Added 93.75%	12,400 $1.14 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $159,264 - $220,941	-2,100 Reduced 24.71%	6,400 $814,000
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $547,740 - $884,935	8,500 New	8,500 $1.34 Million

173

104M

827K

1.23M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $70.2M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.